Association between serum insulin-like growth factor (IGF) I and IGF binding protein-3 and lung function

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2452-2458

  Gläser, Sven ^a   Friedrich, Nele ^a   Ewert, Ralf ^a   Schäper, Christoph ^a   Nauck, Matthias ^a   Dörr, Marcus ^a   Völzke, Henry ^a   Felix, Stephan B ^a   Krebs, Alexander ^a   Wallaschofski, Henri ^a   Koch, Beate ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BREATHING MUSCLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN EXPERIMENT; INSPIRATORY CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG PRESSURE; LUNG VOLUME; MALE; MUSCLE STRENGTH; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX RATIO; SMOKING; SOCIOECONOMICS;

EID: 67650215152     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2662     Document Type: Article

References (43)

1. Adams GR, Haddad F 1996 The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 81:2509-2516
2. Eliakim A, Brasel JA, Barstow TJ, Mohan S, Cooper DM 1998 Peak oxygen uptake, muscle volume, and the growth hormone-insulin-like growth factor-I axis in adolescent males. Med Sci Sports Exerc 30:512-517
3. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
4. Anversa P 2005 Aging and longevity: the IGF-1 enigma. Circ Res 97:411-414
5. Bartke A, Chandrashekar V, Dominici F, Turyn D, Kinney B, Steger R, Kopchick JJ 2003 Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontology 4:1-8
6. Creutzberg EC, Casaburi R 2003 Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:76s-80s
7. Vogiatzis I, Stratakos G, Simoes DC, Terzis G, Georgiadou O, Roussos C, Zakynthinos S 2007 Effects of rehabilitative exercise on peripheral muscle TNFα, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax 62:950-956
8. Bayes-Genis A, Conover CA, Schwartz RS 2000 The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86:125-130
9. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW 1998 Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 levels in healthy elderly individuals. Relation to self-reported quality of health and disability. Gerontology 44:277-280
10. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T 2002 Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106:939-944
11. Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM 2008 High insulin-like growth factor binding protein 1 level predicts incident congestive heart failure in the elderly. Am Heart J 155:1006-1012
12. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D 2004 The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 89:114-120
13. Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D, Wilson PW 2003 Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 139:642-648
14. Yamaguchi H, Komamura K, Choraku M, Hirono A, Takamori N, Tamura K, Akaike M, Azuma H 2008 Impact of serum insulin-like growth factor-1 on early prognosis in acute myocardial infarction. Intern Med 47:819-825
15. Moschos SJ, Mantzoros CS 2002 The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63:317-332
16. Samani AA, Yakar S, LeRoith D, Brodt P 2007 The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20-47
17. Merola B, Longobardi S, Sofia M, Pivonello R, Micco A, Di Rella F, Esposito V, Colao A, Lombardi G 1996 Lung volumes and respiratory muscle strength in adult patients with childhood- or adult-onset growth hormone deficiency: effect of 12 months' growth hormone replacement therapy. Eur J Endocrinol 135:553-558
18. Colao A, Ferone D, Marzullo P, Lombardi G 2004 Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102-152
19. Brody JS, Fisher AB, Gocmen A, DuBois AB 1970 Acromegalic pneumonomegaly: lung growth in the adult. J Clin Invest 49:1051-1060
20. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S, Kessler C 2001 Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 46:186-194
21. Keil U, Stieber J, Döring A, Chambless L, Härtel U, Filipiak B, Hense HW, Tietze M, Gostomzyk JG 1988 The cardiovascular risk factor profile in the study area Augsburg. Results from the first MONICA survey 1984/85. Acta Med Scand Suppl 728:119-128
22. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC 1993 Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16:5-40
23. World Health Organization 1988 Measuring obesity: classification and description of anthropometric data: report on a WHO consultation on the epidemiology of obesity. Copenhagen: WHO Regional Office for Europe, Nutrition Unit
24. 1987 Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 136:1285-1298
25. 1987 Standardization of spirometry-1987 update. Official statement of American Thoracic Society. Respir Care 32:1039-1060
26. 2002 ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518-624
27. Gatford KL, Egan AR, Clarke IJ, Owens PC 1998 Sexual dimorphism of the somatotrophic axis. J Endocrinol 157:373-389
28. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA 1997 Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550-555
29. Johansson AG 1999 Gender difference in growth hormone response in adults. J Endocrinol Invest 22(5 Suppl):58-60
30. Johansson AG, Engström BE, Ljunghall S, Karlsson FA, Burman P 1999 Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 84:2002-2007
31. Span JP, Pieters GF, Sweep FG, Hermus AR, Smals AG 2001 Gender differences in rhGH-induced changes in body composition in GH-deficient adults. J Clin Endocrinol Metab 86:4161-4165
32. Ezzat S, Fear S, Gaillard RC, Gayle C, Landy H, Marcovitz S, Mattioni T, Nussey S, Rees A, Svanberg E 2002 Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults. J Clin Endocrinol Metab 87:2725-2733
33. Brugts MP, van den Beld AW, Hofland LJ, van der Wansem K, van Koetsveld PM, Frystyk J, Lamberts SW, Janssen JA 2008 Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. J Clin Endocrinol Metab 93:2515-2522
34. Saydah S, Graubard B, Ballard-Barbash R, Berrigan D 2007 Insulin-like growth factors and subsequent risk of mortality in the United States. Am J Epidemiol 166:518-526
35. Beaty TH, Cohen BH, Newill CA, Menkes HA, Diamond EL, Chen CJ 1982 Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol 116:102-113
36. Schünemann HJ, Dorn J, Grant BJ, Winkelstein Jr W, Trevisan M 2000 Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118:656-664
37. Scalvini S, Volterrani M, Vitacca M, Clark AL, Solfrini R, Panzali AM, Ferrari R, Levi GF 1996 Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease. Monaldi Arch Chest Dis 51:380-386
38. Mador MJ, Bozkanat E 2001 Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2:216-224
39. Khadempour MH, Ofulue AF, Sekhon HS, Cherukupalli KM, Thurlbeck WM 1992 Changes of growth hormone, somatomedin C, and bombesin following pneumonectomy. Exp Lung Res 18:421-432
40. Noveral JP, Bhala A, Hintz RL, Grunstein MM, Cohen P 1994 Insulin-like growth factor axis in airway smooth muscle cells. Am J Physiol 267:L761-L765
41. Rich CB, Ewton DZ, Martin BM, Florini JR, Bashir M, Rosenbloom J, Foster JA 1992 IGF-I regulation of elastogenesis: comparison of aortic and lung cells. Am J Physiol 263:L276-L282
42. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 41:85-93
43. Friedrich N, Alte D, Völzke H, Spilcke-Liss E, Lüdemann J, Lerch MM, Kohlmann T, Nauck M, Wallaschofski H 2008 Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Growth Horm IGF Res 18:228-237